BiocardiaInc Stock Target Price and Analyst Consensus
BCDA Stock | USD 0.37 0.01 2.78% |
The current analyst and expert consensus on BiocardiaInc is Buy, with no strong buy opinions. The current projected BiocardiaInc target price consensus is 4.00 with 1 analyst opinions. The most common way BiocardiaInc analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview BiocardiaInc executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on BiocardiaInc. We encourage you to use your own analysis of BiocardiaInc to validate this buy or sell advice. BiocardiaInc buy-or-sell recommendation module provides average expert sentiment on the projected BiocardiaInc target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on BiocardiaInc to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade BiocardiaInc Stock refer to our How to Trade BiocardiaInc Stock guide.
Lowest Forecast 3.64 | Highest Forecast 4.44 | Target Price 4 |
BiocardiaInc |
It's important to approach BiocardiaInc's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize BiocardiaInc price targets
BiocardiaInc's stock target price is an estimate of its future price, usually made by analysts. Using BiocardiaInc's target price to determine if it is a suitable investment can be done through the following steps:- Look at BiocardiaInc's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if BiocardiaInc's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional BiocardiaInc Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of BiocardiaInc is a key component of BiocardiaInc valuation and have some predictive power on the future returns of a BiocardiaInc.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of BiocardiaInc's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.Cash Cows Invested a lot of shares | ||
Manufacturing Invested over 40 shares | ||
Momentum Invested over 50 shares | ||
Hedge Favorites Invested few shares | ||
Automobiles and Trucks Invested over 70 shares | ||
Power Assets Invested over 200 shares | ||
Check out Macroaxis Advice on BiocardiaInc to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade BiocardiaInc Stock refer to our How to Trade BiocardiaInc Stock guide.Note that the BiocardiaInc information on this page should be used as a complementary analysis to other BiocardiaInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for BiocardiaInc Stock analysis
When running BiocardiaInc's price analysis, check to measure BiocardiaInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BiocardiaInc is operating at the current time. Most of BiocardiaInc's value examination focuses on studying past and present price action to predict the probability of BiocardiaInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BiocardiaInc's price. Additionally, you may evaluate how the addition of BiocardiaInc to your portfolios can decrease your overall portfolio volatility.
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |
The data published in BiocardiaInc's official financial statements usually reflect BiocardiaInc's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of BiocardiaInc. For example, before you start analyzing numbers published by BiocardiaInc accountants, it's critical to develop an understanding of what BiocardiaInc's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of BiocardiaInc's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, BiocardiaInc's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in BiocardiaInc's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of BiocardiaInc. Please utilize our Beneish M Score to check the likelihood of BiocardiaInc's management manipulating its earnings.